A comparative study of different methods for automatic identification of clopidogrel-induced bleeding in electronic health records
|
|
- Priscilla Williams
- 6 years ago
- Views:
Transcription
1 A comparative study of different methods for automatic identification of clopidogrel-induced bleeding in electronic health records Hee-Jin Lee School of Biomedical Informatics The University of Texas Health Science Center at Houston
2 Introduction Pharmacogenomics The study of how genes affect a person s response to drugs Identifying common and rare genetic variants that contribute to drug efficacy and toxicity (e.g., adverse drug events, ADR) Identifying patients with specific ADR from EHR Costly and time consuming Automatic tools for ADR identification have been investigated. 2
3 Clopidogrel-induced bleeding Clopidogrel for coronary artery disease Often in association with aspirin (dual anti-platelet therapy, DAPT) Recommended by current guidelines Potentially life-threatening adverse bleeding by clopidogrel Genetically determined response Only 12% of the inter-individual variations are explained so far. On going study at Vanderbilt University Medical Center (VUMC) 3
4 Overview Automatic identification of clopidogrel-induced bleeding from EHR Use both structured and narrative data Comparative study of different features and classification methods EHR at VUMC Ini3al Screening Candidate Pa3ents Feature Extraction Features Automatic Classification Case Non-case 4
5 Data 2,268 candidate patients Patients who potentially had clopidogrel-induced bleeding Screening criterion: at least one bleeding ICD-9 code within the time period of clopidogrel mentions in a patient s medical record Manual classification into case or non-case 1,921 cases of clopidogrel-induced bleeding 347 non-cases Splitting into training/test set 1,521 patients for training 756 patients for test 5
6 Features Bleeding information Bleeding ICD-9 codes E.g , blood in stool (109 codes curated by experts) Bleeding CUIs as identified by KMCI (KnowledgeMap Concept Identifier) E.g. C , bleeding from larynx (465 CUIs curated by experts) Bleeding keywords E.g. epistaxis, melena (51 keywords curated by experts) Clopidogrel information Clopidogrel mention and signature (i.e., dosage, route, frequency, etc.) as identified by MedEx 6
7 Features Temporality between bleeding and clopidogrel Timestamps of bleeding, clopidogrel exposure, or other possible causes of bleeding (e.g., chest tube, stab wound ) Shortest time durations between clopidogrel exposure and bleeding, and between other possible causes of bleeding and bleeding Explicit evidence from physicians assertion E.g., Bleeding was substantial owing to the fact that the patient was on DAPT with aspirin and clopidogrel. Identified by simple rule: both clopidogrel and bleeding mention in a sentence without any negation 7
8 Classification methods Rule-based methods Temporality rule: case if there was bleeding after a mention of clopidogrel without any other possible bleeding causes in-between. Explicit evidence rule: case if there is an explicit evidence of clopidogrel-caused bleeding. Machine learning-based methods SVM classifier Bleeding, clopidogrel, temporality, and explicit evidence features and their combinations 8
9 Classification methods Scoring-based methods Use both temporality features and explicit evidence features. s = W duration (1 f duration /10, 000) +W explicit f explicit F duration S f duration f explicit W duration,w explicit score shortest 3me dura3on from clopidogrel exposure to bleeding existence of explicit evidence of clopidogrel-caused bleeding weights case if s cutoff, non-case otherwise. 9
10 Results Category System Description P R F + temporality rule Rule + explicit evidence rule union of temporality and explicit evidence rules bleeding and clopidogrel features ML + temporality feature explicit evidence feature temporality and explicit evidence features cutoff = Scoring cutoff = cutoff =
11 Results Explicit evidence feature shows the best precision. Combination of temporality feature and explicit evidence feature shows the best F-score. Overall, ML-based and scoring-based systems outperforms rule-based systems (F-score). When targeting 95% precision level, scoring system with cutoff 6 may be the best choice. 11
12 Error case Date: September 20th 2011 Recent episode of gross hematuria at OSH with resultant demand ischemia and NSTEMI. "Per Urology, no obvious source of hematuria and has not reoccured in house, will proceed with andcoaguadon and LHC. Please take plavix for three more days total. Bleeding in the past No bleeding as of Sep. 20th Taking clopidogrel as of Sep. 20th non-case, but identified as case by the systems Detailed analysis on temporality and drug status is required. 12
13 Summary Informatics approaches for identifying patients with clopidogrel-induced adverse bleeding. Useful features Temporality between clopidogrel and bleeding Textual evidence from physicians assertion Comparison of different classification methods ML and scoring methods are effective in terms of F-score. Scoring method can achieve a high precision with a reasonable recall. 13
14 Discussion The gold standard data set (candidate patients) was generated using ad-hoc rules. Different criteria for candidate case selection would result in different precision and recall. The generalizability of the findings from this study may need further validation. Application of the proposed methods to other ADR types would require additional manual work. 14
15 Acknowledgements University of Texas Health Science Center at Houston Min Jiang PhD Yonghui Wu PhD Hua Xu PhD Vanderbilt University School of Medicine Christian M. Shaffer MS John H. Cleator MD Eitan A. Friedman MD Dan M. Roden MD Josh Denny MD,MS University of Maryland School of Medicine Joshua P. Lewis MD 15
16 Thank you!!! Questions? 16
CLAMP-Cancer an NLP tool to facilitate cancer research using EHRs Hua Xu, PhD
CLAMP-Cancer an NLP tool to facilitate cancer research using EHRs Hua Xu, PhD School of Biomedical Informatics The University of Texas Health Science Center at Houston 1 Advancing Cancer Pharmacoepidemiology
More informationA long journey to short abbreviations: developing an open-source framework for clinical abbreviation recognition and disambiguation (CARD)
Journal of the American Medical Informatics Association, 24(e1), 2017, e79 e86 doi: 10.1093/jamia/ocw109 Advance Access Publication Date: 18 August 2016 Research and Applications Research and Applications
More informationBuilding a framework for handling clinical abbreviations a long journey of understanding shortened words "
Building a framework for handling clinical abbreviations a long journey of understanding shortened words " Yonghui Wu 1 PhD, Joshua C. Denny 2 MD MS, S. Trent Rosenbloom 2 MD MPH, Randolph A. Miller 2
More information325 mg aspirin and plavix
325 mg aspirin and plavix 12-3-2006 Background Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for. Compare Aspirin
More informationImplementation of Pharmacogenomics in Clinical Medicine in the USA
Implementation of Pharmacogenomics in Clinical Medicine in the USA Dan M. Roden, MD Senior Vice President for Personalized Medicine Vanderbilt University Medical Center, Nashville, TN The vision "Here's
More informationPlavix duration of effect
Plavix duration of effect The Borg System is 100 % Plavix duration of effect Jan 20, 2015. If you have had stent placement after balloon angioplasty for coronary artery disease you will be placed on medications
More informationJOINT MEETING OF CORONARY REVASCULARIZATION 2014 TIONG LEE LEN SENIOR RESEARCH PHARMACIST CLINICAL RESEARCH CENTER, SARAWAK GENERAL HOSPITAL
The Effect of Non Steady State and Steady State Clopidogrel Carboxylic Acid Plasma Concentration on Clopidogrel Responsiveness in Patients Planned For Percutaneous Coronary Intervention JOINT MEETING OF
More informationText mining for lung cancer cases over large patient admission data. David Martinez, Lawrence Cavedon, Zaf Alam, Christopher Bain, Karin Verspoor
Text mining for lung cancer cases over large patient admission data David Martinez, Lawrence Cavedon, Zaf Alam, Christopher Bain, Karin Verspoor Opportunities for Biomedical Informatics Increasing roll-out
More informationA Predictive Chronological Model of Multiple Clinical Observations T R A V I S G O O D W I N A N D S A N D A M. H A R A B A G I U
A Predictive Chronological Model of Multiple Clinical Observations T R A V I S G O O D W I N A N D S A N D A M. H A R A B A G I U T H E U N I V E R S I T Y O F T E X A S A T D A L L A S H U M A N L A N
More informationCOMPARISON OF BREAST CANCER STAGING IN NATURAL LANGUAGE TEXT AND SNOMED ANNOTATED TEXT
Volume 116 No. 21 2017, 243-249 ISSN: 1311-8080 (printed version); ISSN: 1314-3395 (on-line version) url: http://www.ijpam.eu ijpam.eu COMPARISON OF BREAST CANCER STAGING IN NATURAL LANGUAGE TEXT AND SNOMED
More informationPharmacogenomics with Clopidogrel: Does One Size Fit All?
Pharmacogenomics with Clopidogrel: Does One Size Fit All? Leah A. Sabato, PharmD PGY-1 Pharmacy Practice Resident UC Health - University of Cincinnati Medical Center leah.sabato@uchealth.com April 2015
More informationClinical Event Detection with Hybrid Neural Architecture
Clinical Event Detection with Hybrid Neural Architecture Adyasha Maharana Biomedical and Health Informatics University of Washington, Seattle adyasha@uw.edu Meliha Yetisgen Biomedical and Health Informatics
More informationWhen and how to combine antiplatelet agents and anticoagulant?
When and how to combine antiplatelet agents and anticoagulant? Christophe Beauloye, MD, PhD Head, Division of Cardiology Cliniques Universitaires Saint-Luc Brussels, Belgium Introduction Anticoagulation
More informationOUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.
OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To review the use of antiplatelet agents and oral
More informationChapter 12 Conclusions and Outlook
Chapter 12 Conclusions and Outlook In this book research in clinical text mining from the early days in 1970 up to now (2017) has been compiled. This book provided information on paper based patient record
More informationA Study of Abbreviations in Clinical Notes Hua Xu MS, MA 1, Peter D. Stetson, MD, MA 1, 2, Carol Friedman Ph.D. 1
A Study of Abbreviations in Clinical Notes Hua Xu MS, MA 1, Peter D. Stetson, MD, MA 1, 2, Carol Friedman Ph.D. 1 1 Department of Biomedical Informatics, Columbia University, New York, NY, USA 2 Department
More information8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None
Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac
More informationEliquis and plavix combination therapy
Eliquis and plavix combination therapy ELIQUIS Dosing for Patients With NVAF. patients treated with aspirin or the combination of bleeding or completion of a course of therapy,. 9-11-2011 Thrombosis is
More informationNatural Language Processing for EHR-Based Computational Phenotyping
IEEE TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (ACCEPTED) 1 Natural Language Processing for EHR-Based Computational Phenotyping Zexian Zeng, Yu Deng, Xiaoyu Li, Tristan Naumann, Yuan Luo
More informationRetrieving disorders and findings: Results using SNOMED CT and NegEx adapted for Swedish
Retrieving disorders and findings: Results using SNOMED CT and NegEx adapted for Swedish Maria Skeppstedt 1,HerculesDalianis 1,andGunnarHNilsson 2 1 Department of Computer and Systems Sciences (DSV)/Stockholm
More informationSupplementary Online Content
Supplementary Online Content Guimarães PO, Krishnamoorthy A, Kaltenbach LA, et al. Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction: a secondary
More informationLow Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1)
Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1) Caitlin C. Akerman, PharmD PGY2 Cardiology Resident WakeMed Health & Hospitals Raleigh,
More informationPrasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center
Prasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center Hospitalizations in the U.S. Due to ACS Acute Coronary Syndromes
More informationAngelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017
Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations
More informationAuthor: K. Ketchum Date: July 2015
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationPeripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment
Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment Prepared and Presented by Jon Manocchio, Pharm D Blanchard Valley Hospital October 2011 Introduction PAD is a condition that is
More informationAntiplatelet and Anti-Thrombotic Therapy. Ivan Anderson, MD RIHVH Cardiology
Antiplatelet and Anti-Thrombotic Therapy Ivan Anderson, MD RIHVH Cardiology Outline Anti-thrombotic therapy Risk stratification of stroke with atrial fibrillation DVT and PE treatment Pharmacology Anti-platelet
More informationFDA Workshop NLP to Extract Information from Clinical Text
FDA Workshop NLP to Extract Information from Clinical Text Murthy Devarakonda, Ph.D. Distinguished Research Staff Member PI for Watson Patient Records Analytics Project IBM Research mdev@us.ibm.com *This
More informationA Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions
Drug Saf (2015) 38:895 908 DOI 10.1007/s40264-015-0314-8 ORIGINAL RESEARCH ARTICLE A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug
More informationHHS Public Access Author manuscript Stud Health Technol Inform. Author manuscript; available in PMC 2016 July 22.
Analyzing Differences between Chinese and English Clinical Text: A Cross-Institution Comparison of Discharge Summaries in Two Languages Yonghui Wu a,*, Jianbo Lei a,b,*, Wei-Qi Wei c, Buzhou Tang a, Joshua
More informationYes No Unknown. Major Infection Information
Rehospitalization Intervention Check any that occurred during this hospitalization. Pacemaker without ICD ICD Atrial arrhythmia ablation Ventricular arrhythmia ablation Cardioversion CABG (coronary artery
More informationExtracting genetic alteration information for personalized cancer therapy from ClinicalTrials.gov
Extracting genetic alteration information for personalized cancer therapy from ClinicalTrials.gov RECEIVED 15 September 2015 REVISED 7 December 2015 ACCEPTED 13 January 2016 PUBLISHED ONLINE FIRST 24 March
More informationSUPRA PUBIC CATHETER(SPC)
Suprapubic versus urethral catheter? When a long-term catheter to drain the bladder is advised, it can be placed in the urethra (water pipe) or suprapubically (directly into the bladder through the skin
More informationLaparoscopic Radical Removal of the Kidney +/- Ureter
Who can I contact if I have a problem when I get home? If you experience any problems related to your surgery or admission once you have been discharged home. Please feel free to contact 4A, 4B or 4C ward
More informationFIXATION OF A RETRACTILE TESTIS
Procedure Specific Information What is the evidence base for this information? This publication includes advice from consensus panels, the British Association of Urological Surgeons, the Department of
More informationPreoperative Management of Patients Receiving Antithrombotics
Preoperative Management of Patients Receiving Antithrombotics Bleeding complications remain an important concern for most surgical procedures. Attempts to minimize the risk of these complications by removing
More informationIBM Research Report. Automated Problem List Generation from Electronic Medical Records in IBM Watson
RC25496 (WAT1409-068) September 24, 2014 Computer Science IBM Research Report Automated Problem List Generation from Electronic Medical Records in IBM Watson Murthy Devarakonda, Ching-Huei Tsou IBM Research
More informationKnowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains
Knowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains Dr. Sascha Losko, Dr. Karsten Wenger, Dr. Wenzel Kalus, Dr. Andrea Ramge, Dr. Jens Wiehler,
More informationCrackCast Episode 30 GI Bleeding
CrackCast Episode 30 GI Bleeding Episode overview: 1) List 5 causes of UGIB in adults and pediatrics 2) List 5 causes of LGIB in adults and pediatrics 3) Describe your management approach for severe UGIB
More informationWhat is precision medicine and how has it evolved over time? Sara Van Driest, MD, PhD Vanderbilt University Medical Center March 2, 2016
What is precision medicine and how has it evolved over time? Sara Van Driest, MD, PhD Vanderbilt University Medical Center March 2, 2016 What is Precision Medicine Precision medicine is an emerging approach
More informationFactuality Levels of Diagnoses in Swedish Clinical Text
User Centred Networked Health Care A. Moen et al. (Eds.) IOS Press, 2011 2011 European Federation for Medical Informatics. All rights reserved. doi:10.3233/978-1-60750-806-9-559 559 Factuality Levels of
More informationAsthma Surveillance Using Social Media Data
Asthma Surveillance Using Social Media Data Wenli Zhang 1, Sudha Ram 1, Mark Burkart 2, Max Williams 2, and Yolande Pengetnze 2 University of Arizona 1, PCCI-Parkland Center for Clinical Innovation 2 {wenlizhang,
More informationTiming of Surgery After Percutaneous Coronary Intervention
Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet
More informationA Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS
A Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS Magnus Ohman MB, on behalf of the GEMINI-ACS-1 Investigators
More informationJoint Meeting of Coronary Revascularization 8 th to 9 th December 2017
B Joint Meeting of Coronary Revascularization 8 th to 9 th December 2017 A Novel Clinical Application Combining Genotyping and Platetlet Function Testing In Patients With Acs - A Case Series Shirley Tan
More information3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.
Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations
More informationOn-time clinical phenotype prediction based on narrative reports
On-time clinical phenotype prediction based on narrative reports Cosmin A. Bejan, PhD 1, Lucy Vanderwende, PhD 2,1, Heather L. Evans, MD, MS 3, Mark M. Wurfel, MD, PhD 4, Meliha Yetisgen-Yildiz, PhD 1,5
More informationComparing ICD9-Encoded Diagnoses and NLP-Processed Discharge Summaries for Clinical Trials Pre-Screening: A Case Study
Comparing ICD9-Encoded Diagnoses and NLP-Processed Discharge Summaries for Clinical Trials Pre-Screening: A Case Study Li Li, MS, Herbert S. Chase, MD, Chintan O. Patel, MS Carol Friedman, PhD, Chunhua
More informationAuthors: Shuling Li, PhD 1, Julia Molony, MS 1, Karynsa Cetin, MPH 2, Jeffrey Wasser, MD 3, Ivy Altomare, MD 4
Rate of Bleeding-Related Episodes (BREs) in Elderly Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study Using Medicare 20% Sample Data Authors: Shuling Li,
More informationPartial Removal of the Kidney
Who can I contact if I have a problem when I get home? If you experience any problems related to your surgery or admission once you have been discharged home. Please feel free to contact Ward 4A, 4B or
More informationUW MEDICINE PATIENT EDUCATION. Treatment for blocked heart arteries DRAFT. What are arteries? How do heart arteries become blocked?
UW MEDICINE PATIENT EDUCATION Complex Percutaneous Coronary Intervention (PCI) Treatment for blocked heart arteries This handout explains complex percutaneous intervention (PCI) treatment of a coronary
More informationOpen Radical Removal of the Kidney
Who can I contact if I have a problem when I get home? If you experience any problems related to your surgery or admission once you have been discharged home. Please feel free to contact 4A, 4B or 4C ward
More informationCase-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials
Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials Riccardo Miotto and Chunhua Weng Department of Biomedical Informatics Columbia University,
More informationExtracting geographic locations from the literature for virus phylogeography using supervised and distant supervision methods
Extracting geographic locations from the literature for virus phylogeography using supervised and distant supervision methods D. Weissenbacher 1, A. Sarker 2, T. Tahsin 1, G. Gonzalez 2 and M. Scotch 1
More informationThe Dual Antiplatelet Therapy (DAPT) Trial: An FDA Perspective
The Dual Antiplatelet Therapy (DAPT) Trial: An FDA Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological
More informationAcute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine
Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute
More informationTeamHCMUS: Analysis of Clinical Text
TeamHCMUS: Analysis of Clinical Text Nghia Huynh Faculty of Information Technology University of Science, Ho Chi Minh City, Vietnam huynhnghiavn@gmail.com Quoc Ho Faculty of Information Technology University
More informationChapter 2. The Research Process: Coming to Terms Pearson Prentice Hall, Salkind. 1
Chapter 2 The Research Process: Coming to Terms 2009 Pearson Prentice Hall, Salkind. 1 CHAPTER OBJECTIVES - STUDENTS SHOULD BE ABLE TO: Describe the research process from formulating questions to seeking
More informationUroradiology For Medical Students
Uroradiology For Medical Students Lesson 8 Computerized Tomography 2 American Urological Association Objectives In this lesson you will: Gain more experience reading CT images Learn how computer generated
More informationTruth Versus Truthiness in Clinical Data
Temple University Health System Truth Versus Truthiness in Clinical Data Mark Weiner, MD, FACP, FACMI Assistant Dean for Informatics, Temple University School of Medicine mark.weiner@tuhs.temple.edu 1
More informationHealth Informa.cs. Lecture 9. Samantha Kleinberg
Health Informa.cs Lecture 9 Samantha Kleinberg samantha.kleinberg@stevens.edu Next week: journal club For all papers: read, and prepare to comment on For your paper: Read the ar.cle (+ other references
More informationDoncaster & Bassetlaw Medicines Formulary
Doncaster & Bassetlaw Medicines Formulary Section 2.9: Antiplatelet Drugs Aspirin 75mg Dispersible Tablets Aspirin 300mg Dispersible Tablets Aspirin 300mg Suppositories Clopidogrel 75mg Tablets Dipyridamole
More information2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older)
2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures)
More informationBleeding Management Strategies. Aiming for the best Outcomes August 27, Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM
Bleeding Management Strategies Aiming for the best Outcomes August 27, 2016 Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM Learning Objectives Review the use of anti-coagulants in patients
More informationOptimal Duration of Dual Anti- Platelet Therapy. December 19, 2015
Optimal Duration of Dual Anti- Platelet Therapy December 19, 2015 John S. MacGregor, M.D., Ph.D. Professor of Medicine University of California San Francisco Source: The New Yorker 1 Optimal Duration of
More informationThrombosis Research active studies
Thrombosis Research active studies A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients With Coronary Artery Disease Undergoing PCI With CYP2C19 Loss-of-function Genotypes: A Feasibility
More information- May Help Increase Appropriate Early Use in Acute Coronary Syndrome Patients -
MEDIA INVESTORS Ken Dominski John Elicker Bristol-Myers Squibb Bristol-Myers Squibb 609-252-5251 212-546-3775 ken.dominski@bms.com john.elicker@bms.com Amy Ba Felix Lauscher sanofi-aventis sanofi-aventis
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 July 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 July 2010 DUOPLAVIN 75 mg/75 mg, film-coated tablet B/30 (CIP code: 359 022-6) B/30 (CIP code: 382 063-7) DUOPLAVIN
More informationHead-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
Date: August 21, 2008 Refer to: Carole Copeland (OUS) Eli Lilly and Company 317-277-3661 (office) 317-610-6196 (cell) Tammy Hull (U.S.A.) Eli Lilly and Company 317-651-9116 (office) 317-614-5132 (cell)
More informationSACRAL NERVE STIMULATION (NEUROMODULATION)
SACRAL NERVE STIMULATION (NEUROMODULATION) What evidence is this information based on? This leaflet includes advice from consensus panels, ICI and ICS. You should read this leaflet with any advice your
More informationAntiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.
Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,
More informationLAPAROSCOPIC RADICAL REMOVAL OF THE KIDNEY INFORMATION FOR PATIENTS
The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E-mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk LAPAROSCOPIC
More informationLaparoscopic partial removal of the kidney
Laparoscopic partial removal of the kidney Department of Urology 2 Patient Information What evidence is this information based on? This booklet includes advice from consensus panels, the British Association
More information2.5 Other Hematology Consult:
The Warfarin Order Sheet has been approved by the P & T committee to be implemented by pharmacists. These orders are not used to treat patients with serious hemorrhagic complications. WARFARIN TARGET INR
More informationSurveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes
Surveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes Naveed Afzal, Sunghwan Sohn, Christopher G. Scott, Hongfang Liu, Iftikhar J. Kullo, Adelaide M. Arruda-Olson
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1
More informationDual Antiplatelet Therapy Made Practical
Dual Antiplatelet Therapy Made Practical David Parra, Pharm.D., FCCP, BCPS Clinical Pharmacy Program Manager in Cardiology/Anticoagulation VISN 8 Pharmacy Benefits Management Clinical Associate Professor
More informationDiagnostic laparoscopy: procedure-specific information
PATIENT INFORMATION Diagnostic laparoscopy: procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels, the British Association of
More informationINFORMATION FOR PATIENTS
The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E- mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk INFORMATION
More informationSimple removal of the kidney (simple nephrectomy): procedure-specific information
PATIENT INFORMATION Simple removal of the kidney (simple nephrectomy): procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels,
More informationThe Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI
The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI Interventional Cardiologist Cardiovascular Institute of the South Director of Cardiovascular Services St. Charles Parish
More informationUpdate on Antiplatelet Therapy
Update on Antiplatelet Therapy Christine Ibarra Pharm.D. PGY-1 Baptist Hospital of Miami Objectives Explain the role of antiplatelettherapy in prevention of cardiovascular events Appreciate differences
More informationBelinda Green, Cardiologist, SDHB, 2016
Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens
More informationLearning Objectives. Epidemiology of Acute Coronary Syndrome
Cardiovascular Update: Antiplatelet therapy in acute coronary syndromes PHILLIP WEEKS, PHARM.D., BCPS-AQ CARDIOLOGY Learning Objectives Interpret guidelines as they relate to constructing an antiplatelet
More informationΠεριφερική Αρτηριακή Νόσος Νόσος Καρωτίδων
Νεώτερα δεδομένα στην αντιαιμοπεταλιακή αγωγή που θα επηρεάσουν τις μελλοντικές κατευθυντήριες οδηγίες Περιφερική Αρτηριακή Νόσος Νόσος Καρωτίδων Μιλτιάδης Ματσάγκας, MD, PhD, FEBVS Αναπληρωτής Καθηγητής
More informationA Probabilistic Reasoning Method for Predicting the Progression of Clinical Findings from Electronic Medical Records
A Probabilistic Reasoning Method for Predicting the Progression of Clinical Findings from Electronic Medical Records Travis Goodwin, Sanda M. Harabagiu, PhD University of Texas at Dallas, Richardson, TX,
More informationApril 24, Seoul, South Korea
Clinical Update of Resolute Integrity with DAPT Pooled RESOLUTE Clinical Program Josiah N. Wilcox, Ph.D. Chief Scientific Officer, Coronary and RDN Medtronic CardioVascular TCT-AP TCT AP April 24, 2013
More informationSTEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology
STEMI update Vijay Krishnamoorthy M.D. Interventional Cardiology OVERVIEW Current Standard of Care in Management of STEMI Update in management of STEMI Pre-Cath Lab In the ED/Office/EMS. Cath Lab Post
More informationWhat oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor
76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class
More informationAnginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial
Angina Anginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial ischemia and pain as well as prevention of myocardial
More informationCystoscopy & Evacuation of Blood Clots
Who can I contact if I have a problem when I get home? If you experience any problems related to your surgery or admission once you have been discharged home. Please feel free to contact 4A, 4B or 4C ward
More informationUTHealth at SemEval-2016 Task 12: an End-to-End System for Temporal Information Extraction from Clinical Notes
UTHealth at SemEval-2016 Task 12: an End-to-End System for Temporal Information Extraction from Clinical Notes Hee-Jin Lee, Yaoyun Zhang, Jun Xu, Sungrim Moon, Jingqi Wang, Yonghui Wu, and Hua Xu University
More informationACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club 1 Optimising Crossover from Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome [CAPITAL OPTI-CROSS] Monique Conway, PharmD, BCPS PGY-2 Cardiology Pharmacy
More informationCYSTOSCOPY AND URETHRAL BULKING INJECTIONS INFORMATION FOR PATIENTS
The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E-mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk CYSTOSCOPY
More informationCystometrogram (Urodynamic Studies)
Who can I contact if I have a problem when I get home? If you experience any problems related to your surgery or admission once you have been discharged home. Please feel free to contact 4A, 4B or 4C ward
More informationRemoval of Epididymal Cyst Urology Patient Information Leaflet
Removal of Epididymal Cyst Urology Patient Information Leaflet Page 1 What is an Epididymal Cyst? Epididymal cysts or as they are sometimes known spermatocele are cysts of the head of the epididymis that
More informationAn unsupervised machine learning model for discovering latent infectious diseases using social media data
Journal of Biomedical Informatics j o u r n al homepage: www.elsevier.com/locate/yj b i n An unsupervised machine learning model for discovering latent infectious diseases using social media data ARTICLE
More informationΔιάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά
Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά International ACS guidelines: Recommendations on duration of dual
More informationA review of approaches to identifying patient phenotype cohorts using electronic health records
A review of approaches to identifying patient phenotype cohorts using electronic health records Shivade, Raghavan, Fosler-Lussier, Embi, Elhadad, Johnson, Lai Chaitanya Shivade JAMIA Journal Club March
More informationAssessing the role of a medication-indication resource in the treatment relation extraction from clinical text
Assessing the role of a medication-indication resource in the treatment relation extraction from clinical text RECEIVED 5 May 2014 REVISED 16 September 2014 ACCEPTED 27 September 2014 PUBLISHED ONLINE
More information